dimanche 15 novembre 2026
RechercherExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each, so you can check any claim. How we source
Source document· June 23, 2026

Health Catalyst, Zoom, and Autodesk Shares Are Falling, What You Need To Know

View original at finance.yahoo.com
Health Catalyst, Zoom, and Autodesk Shares Are Falling, What You Need To Know Health Catalyst, Zoom, and Autodesk Shares Are Falling, What You Need To Know What Happened?…
Opening lines of the source · short snapshot: read the full document at the original

Ce que nous avons tiré de cette source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The software sell-off has become indiscriminate; the market is pricing AI cannibalization as if it already happened while income statements may be indicating otherwise

    60% confidence
  • AI is compressing demand for traditional IT services

    60% confidence
  • If the largest IT services firm in the world signals AI is eating its billable hours, investors will extend the same logic to software vendors whose products those hours configure

    60% confidence
  • Salesforce is a Rule-of-40 company retiring 10% of its shares through a $25 billion buyback

    60% confidence
  • AI agents will erode the subscription model that underpins traditional enterprise software economics

    60% confidence
  • Salesforce carries the largest AI revenue line in the enterprise software category

    60% confidence
  • The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks

    60% confidence
  • Salesforce is acquiring m3ter to monetize AI agent actions rather than per-seat subscriptions

    60% confidence
  • Until enterprise software companies prove AI revenue scales faster than it erodes the legacy subscription base, software stocks may remain in the penalty box even on days when chip stocks rally

    60% confidence
  • Salesforce is a Buy on valuation grounds

    60% confidence

Data points we hold from this source

Salesforce · stock price152 USD
Ce que nous savons · l'intelligence derrière cette page
En direct du substrat
Ce que nous observons
Q4 2026 Biotech Catalyst Cluster: Late-Stage Data and PDUFA Dates Converge
Early-to-mid November 2026 is a dense run of clinical readouts and Q3 earnings at AHA, AASLD, ACR and ASH. Mid-cap biotechs (Vir, Mineralys, Arrowhead, Oryzon, Novartis, J&J) are reporting data that feeds into regulatory decisions. The next ones are the ivonescimab BLA (Nov 14) and the lorundrostat PDUFA (Dec 22), followed by ECLIPSE 2/3 and Maritime-1 readouts in Q1 2027. The list also includes an unrelated delisting track (EGM Nov 19, application Jan 25, 2027), and the facts have no AI or fintech content.
Notre lecture des données ›
Signaux que nous suivons
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Tendances que nous surveillons ›
Là où les sources divergent
Sources réconciliées : aucun conflit ouvert pour l'instant.
Nous signalons les conflits ouvertement ›
Vérifié récemment
✓ Vérifié avec la source d'origine
4,995
faits reliés à leur source, et nous signalons ceux qui ne tiennent pas.
101 entités suivies4,995 faits vérifiés avec la source5,585 documents sources archivés
Interrogez ces données → isubstrate.com
Health Catalyst, Zoom, and Autodesk Shares Are Falling, What You Need To Know: Source | Via News | fr.via.news